Ishita Ayan Dutt, Shine Jacob, Raghav Aggarwal, Bhavini Mishra, Akshara Srivastava, Sohini Das

Stories by Ishita Ayan Dutt, Shine Jacob, Raghav Aggarwal, Bhavini Mishra, Akshara Srivastava, Sohini Das

From Tesla to Mercedes, luxury carmakers head South

From Tesla to Mercedes, luxury carmakers head South

Rediff.com   11 Mar 2025

In 2024 alone, South India saw the highest rise in sales in the luxury segment, with Tamil Nadu reportedly registering a 19.3 per cent increase in premium car registrations from 2022-23

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com   8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

'US tariff issue is an overhanging sword'

'US tariff issue is an overhanging sword'

Rediff.com   7 Mar 2025

Firodia talked about his plans for the EV-components business, and the components business at large for the group

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com   6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Can Tesla Make In India For Below $23,000?

Can Tesla Make In India For Below $23,000?

Rediff.com   5 Mar 2025

The Indian automotive market offers around 1 million units annual volume opportunity at a price above $23,000.

The Lady Judge Who Heads Gujarat UCC Panel

The Lady Judge Who Heads Gujarat UCC Panel

Rediff.com   5 Mar 2025

On the basis of her committee's report, the UCC in Uttarakhand established mandatory registration for marriages and live-in relationships, banned polygamy, and provided equal inheritance rights for women.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com   27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

Mamata Ready To Take On BJP For 2026

Mamata Ready To Take On BJP For 2026

Rediff.com   27 Feb 2025

The TMC-led West Bengal government has already started laying the groundwork for the election, setting the tone with the recent Bengal Global Business Summit and the state Budget.

'It Was Always About The Bride'

'It Was Always About The Bride'

Rediff.com   25 Feb 2025

'Her story, her life, her aspirations and struggles...' 'Indian weddings are not just about fuschia, pink and dancing. They have many nuances.'

Why Tesla Entry is No Major Threat

Why Tesla Entry is No Major Threat

Rediff.com   24 Feb 2025

Tesla needs to either sell the same models with reduced features to lower the cost for Indian market, or incur losses.

Indians Work More Than Chinese!

Indians Work More Than Chinese!

Rediff.com   14 Feb 2025

The average Indian works 46.7 hours per week, surpassing even China's 46.1 hours. In some sectors, the numbers are even more staggering.

'Couples Are Moving Beyond Dinner Dates'

'Couples Are Moving Beyond Dinner Dates'

Rediff.com   13 Feb 2025

With Valentine's Day falling on a Friday, travel is picking up as people look for quick getaways.

USAID Funding To India Declines Amid Trump's Freeze

USAID Funding To India Declines Amid Trump's Freeze

Rediff.com   13 Feb 2025

'If the Bill and Melinda Gates Foundation cuts funds, there could be more impact.'

Trump Order May Delay Adani Case

Trump Order May Delay Adani Case

Rediff.com   12 Feb 2025

'While the current pause offers temporary reprieve and alleviates any immediate legal pressure, the long-term implications remain uncertain.'

Highest Selling New Drug In India Is...

Highest Selling New Drug In India Is...

Rediff.com   11 Feb 2025

Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com   10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

'There is a slowdown in the economy'

'There is a slowdown in the economy'

Rediff.com   7 Feb 2025

'I believe that the overall demand for commercial vehicles will improve, even though there is a slowdown in the GDP.'

'Global barriers to trade are increasing'

'Global barriers to trade are increasing'

Rediff.com   6 Feb 2025

'The steel industry expects the government to decide on safeguard measures from dumping post-Budget'

'Bengal Is In Business'

'Bengal Is In Business'

Rediff.com   6 Feb 2025

'This is the Bengal story, where businesses are nurtured, dreams are realised, and legacies are built.'

Focus On 26 EV Launches, Charging Infra At Auto Expo

Focus On 26 EV Launches, Charging Infra At Auto Expo

Rediff.com   4 Feb 2025

With nearly 100 launches and unveils, the Bharat Mobility Global Expo 2025, held in Delhi from January 17 to 22, made one thing clear to automobile enthusiasts: Electric vehicles (EVs) are the way ahead for the Indian auto market for years to come.